Send to

Choose Destination
North Clin Istanb. 2019 Oct 25;6(4):355-360. doi: 10.14744/nci.2019.24855. eCollection 2019.

Our clinic's first experience with HoLEP.

Author information

Department of Urology, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey.



The present study reports a retrospective evaluation of the first Holmium laser prostate enucleation (HoLEP) cases and their results in our clinic.


Twenty four patients who underwent HoLEP surgery between April 2017 and November 2017 were evaluated for demographic characteristics, duration of operation, amount of hemorrhage, amount of energy used, tissue weight removed, catheterization time and complications. IPSS and uroflowmetry results were compared before and after the surgery.


Patients with hemoglobin, IPSS, uroflowmetry, and voiding speeds (Qmean, Qmax) were compared before and after the surgery. There was a significant difference in IPSS, Qmean and hemoglobin values but not in Qmax, statistically. Our complications rates were correlated with the literature.


HoLEP stands out as a surgical method that can be applied with high confidence in the treatment of benign prostatic hyperplasia and it has similar functional results to gold standard surgeries, causes fewer complications, improves patient comfort due to short catheterization and hospitalization and is more advantageous regarding cost.


Benign prostate hyperplasia; enucleation; holmium laser

Conflict of interest statement

Conflict of Interest: No conflict of interest was declared by the authors.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center